| Full Name | Whitney Mack |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 476 Williams Way, Moab, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598173403 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 125065213 (Illinois) | Secondary |
| 207Q00000X | Family Medicine | 10869093-1204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Nursing Services | West valley city, UT | Home health agency |
| Moab Regional Hospital | Moab, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Moab Valley Healthcare Inc | 2466361720 | 12 |
News Archive
Are cellulose nanocrystals harmful to human health? The answer might depend on the route of exposure, according to a review of the literature by a Virginia Tech scientist, but there have been few studies and many questions remain.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that MagniFuse PC (Posterior Cervical) Bone Graft, a new tissue-based product built upon the Company's proprietary MagniFuse bone graft technology platform, has been used for the first time in a spinal surgery in the United States.
By the time children are in second grade, they know to take what people say with a grain of salt, particularly when the statement supports the speaker's self-interest, according to a published study by Yale researchers.
Novartis today announced that The New England Journal of Medicine (NEJM) published clinical trial results showing the investigational compound LDK378 (ceritinib) achieved an overall response rate (ORR, including complete response [CR] and partial response [PR]) of 58% and a median progression-free survival (PFS) of seven months in adults with advanced anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) who received 400 mg or higher of LDK378 per day.
Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, commends the Centers for Medicare and Medicaid Services for eliminating the so-called "transition adjustment" imposed on dialysis facilities as part of the new Medicare end-stage renal disease prospective payment system.
› Verified 4 days ago
| Entity Name | Moab Valley Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770513236 PECOS PAC ID: 2466361720 Enrollment ID: O20040114000346 |
News Archive
Are cellulose nanocrystals harmful to human health? The answer might depend on the route of exposure, according to a review of the literature by a Virginia Tech scientist, but there have been few studies and many questions remain.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that MagniFuse PC (Posterior Cervical) Bone Graft, a new tissue-based product built upon the Company's proprietary MagniFuse bone graft technology platform, has been used for the first time in a spinal surgery in the United States.
By the time children are in second grade, they know to take what people say with a grain of salt, particularly when the statement supports the speaker's self-interest, according to a published study by Yale researchers.
Novartis today announced that The New England Journal of Medicine (NEJM) published clinical trial results showing the investigational compound LDK378 (ceritinib) achieved an overall response rate (ORR, including complete response [CR] and partial response [PR]) of 58% and a median progression-free survival (PFS) of seven months in adults with advanced anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) who received 400 mg or higher of LDK378 per day.
Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, commends the Centers for Medicare and Medicaid Services for eliminating the so-called "transition adjustment" imposed on dialysis facilities as part of the new Medicare end-stage renal disease prospective payment system.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Whitney Mack, 450 Williams Way, Moab, UT 84532-2185 Ph: (435) 719-3500 | Whitney Mack, 476 Williams Way, Moab, UT 84532-2186 Ph: (435) 719-3500 |
News Archive
Are cellulose nanocrystals harmful to human health? The answer might depend on the route of exposure, according to a review of the literature by a Virginia Tech scientist, but there have been few studies and many questions remain.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that MagniFuse PC (Posterior Cervical) Bone Graft, a new tissue-based product built upon the Company's proprietary MagniFuse bone graft technology platform, has been used for the first time in a spinal surgery in the United States.
By the time children are in second grade, they know to take what people say with a grain of salt, particularly when the statement supports the speaker's self-interest, according to a published study by Yale researchers.
Novartis today announced that The New England Journal of Medicine (NEJM) published clinical trial results showing the investigational compound LDK378 (ceritinib) achieved an overall response rate (ORR, including complete response [CR] and partial response [PR]) of 58% and a median progression-free survival (PFS) of seven months in adults with advanced anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC) who received 400 mg or higher of LDK378 per day.
Kidney Care Partners, a broad-based coalition of patient advocates, dialysis professionals, care providers and manufacturers, commends the Centers for Medicare and Medicaid Services for eliminating the so-called "transition adjustment" imposed on dialysis facilities as part of the new Medicare end-stage renal disease prospective payment system.
› Verified 4 days ago
Kenneth Lewis Williams, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 476 Williams Way, Ste A, Moab, UT 84532 Phone: 435-259-7121 Fax: 435-259-3112 | |
Paul Michael Johnson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 Williams Way, Moab, UT 84532 Phone: 435-719-3500 | |
Mr. Ray Allen Andrew, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 255 Williams Way, Moab, UT 84532 Phone: 435-259-4466 | |
Dr. Donald Nilan Marquardt, PHD, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 267 N Main St, Moab, UT 84532 Phone: 435-259-5276 Fax: 435-259-5277 | |
Dylan Cole, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 476 Williams Way, Suite A, Moab, UT 84532 Phone: 435-259-7121 Fax: 435-259-3112 | |
Steven V Rouzer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 380 North 500 West, Moab, UT 84532 Phone: 435-259-0408 Fax: 435-259-0448 | |
Dr. Patrick Mark Scherer, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 450 Williams Way, Moab, UT 84532 Phone: 435-719-3500 |